Selected physical and chemical properties of feverfew (Tanacetum parthenium) extracts important for formulated product quality and performance

AAPS PharmSciTech

Volumn 9, Issue 1, 2008, Pages 22-30

  Jin, Ping ^a,b   Madieh, Shadi ^a,c   Augsburger, Larry L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNITED STATES PHARMACOPEIA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Botanical; Compactibility; Compressibility; Feverfew; Flowability; Hygroscopicity; Parthenolide

Indexed keywords

PARTHENOLIDE; TANACETUM PARTHENIUM EXTRACT; PLANT EXTRACT;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG ISOLATION; DRUG LABELING; DRUG MANUFACTURE; DRUG QUALITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; MOISTURE; PHYSICAL CHEMISTRY; QUALITY CONTROL; TABLET COMPRESSION; TANACETUM PARTHENIUM; TENSILE STRENGTH; VALIDATION PROCESS; WETTABILITY; CHEMISTRY; COMPRESSIVE STRENGTH; DRUG SCREENING; EVALUATION; HARDNESS; METHODOLOGY; MOLECULAR WEIGHT; POWDER; SOLUBILITY; VISCOSITY;

COMPRESSIVE STRENGTH; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HARDNESS; MOLECULAR WEIGHT; PLANT EXTRACTS; POWDERS; SOLUBILITY; TANACETUM PARTHENIUM; VISCOSITY;

EID: 44849141135     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-007-9017-5     Document Type: Article

References (18)

1. Health Canada. Feverfew 2006 http://www.hc-sc.gc.ca/dhp-mps/alt_formats/ hpfb-dgpsa/pdf/prodnatur/mono_feverfew-camomille_e.pdf.
2. K. J. Kemper. Feverfew (Tanacetum pathenium). http://www.longwoodherbal.org/feverfew/feverfew.pdf.
3. B. Marchand, H. M. Behl, E. Rodriguez. Application of high-performance liquid chromatography for analysis and isolation of sesquiterpene lactones. J. Chromatogr 265:97-104 (1983).
4. D. Awang, B. A. Dawson, D. Kindack. Parthenolide content of feverfew (Tanacetum parthenium) assessed by HPLC and NMR spectroscopy. J. Nat. Prod 54(6):1516-1521 (1991).
5. S. Heptinstall, D. V. Awang, B. A. Dawson, D. Kindack, D. W. Knight, J. May. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. J. Pharm. Pharmacol 44(5):391-395 (1992) May.
6. E. A. Abourashed, I. A. Khan, E. A. Abourashed, I. A. Khan. Determination of parthenolide in selected feverfew products by liquid chromatography. J. AOAC Int. 83(4):789-792 (2000) Jul-Aug.
7. J. Z. Zhou, X. Kou, D. Stevenson. Rapid extraction and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium). J. Agric. Food Chem. 47(3):1018-1022 (1999) Mar.
8. The United States Pharmacopeia. 30th ed., US Pharmacopeial Convention, Inc., Rockville, MD, 2007.
9. A. H. Draves, S. E. Walker. Parthenolide content of Canadian commercial feverfew preparations: Label claims are misleading in most cases. Pharm. Res. Rev 136(10):23-30 (2004).
10. R. L. Carr. Particle behavior, storage and flow. Brit. Chem. Eng. 15:1541-1549 (1970).
11. A. Gioia. Intrinsic flowability: A new technology for powder flowability classification. Pharm Technol. (2):65-68 (1980).
12. J. C. Cellahan, G. W. Cleary, M. Elefant, G. Kaplan. Equilibrium moisture content of pharmaceutical excipients. Drug. Dev. Ind. Pharm. 8(3):355-369 (1982).
13. J. K. Prescott, R. A. Barnum. On powder flowability. Pharm. Technol. 60(10):60-84 (2000).
14. F. Podczeck, J. M. Newton. Powder and capsule filling properties of lubricated granulated cellulose powder. Eur. J. Pharm. Biopharm 50(3):373-377 (2000) Nov.
15. Stability Testing of New Drug Substances and Products.: ICH Expert Working Group; 2003.
16. A. Endale, P. C. Schmidt, T. Gebre-Mariam. Standardisation and physicochemical characterisation of the extracts of seeds of Glinus lotoides. Pharmazie 59(1):34-38 (2004) Jan.
17. R. W Heckel. Density-pressure relationship in powder compaction. Trans. Met. Soc. A. I. M. E 221:671-675 (1961).
18. P. Jin, S. Madieh, and L. L. Augsburger. The Solution and Solid State Stability and Excipient Compatibility of Parthenolide in Feverfew, AAPS PharmSciTech (2007) (in press).